Poor Sleep: The Hormonal, Nutritional, and Lifestyle Drivers and How to Fix Them

Why Poor Sleep Is a Systemic Problem, Not Just a Nighttime One

Sleep is the body's master reset. During deep slow-wave sleep, growth hormone is secreted in its largest daily pulse, immune cells consolidate memory of pathogens they've encountered, and the glymphatic system flushes amyloid beta and other metabolic waste from the brain (Xie et al., Science 2013; PMID: 24136970). When sleep is fragmented or curtailed, none of that happens efficiently.

The downstream effects compound quickly. A single night of four hours of sleep has been shown to reduce natural killer cell activity by 70% compared to a full eight-hour night (Irwin et al., JAMA Internal Medicine 2016; PMID: 26571096). Over weeks and months, chronic sleep restriction elevates fasting insulin, dysregulates appetite hormones ghrelin and leptin, and accelerates cellular aging through increased oxidative stress.

Yet most people treat poor sleep with a single intervention — usually a melatonin gummy or an antihistamine — without addressing why their sleep architecture broke down in the first place. The honest answer is almost always multifactorial: a combination of dysregulated cortisol, micronutrient deficiencies, and habits that suppress the body's natural sleep drive.

This article breaks down each driver with the supporting science and maps it onto the specific supplements and lifestyle changes that the clinical evidence actually supports.

---

Cortisol and Sleep: The Hormone That Keeps You Wired at Night

Cortisol follows a precise 24-hour rhythm in healthy adults: it peaks within 30–45 minutes of waking (the cortisol awakening response), declines steadily through the afternoon, and reaches its nadir around midnight. This trough is what allows melatonin to rise and initiate sleep onset. When that rhythm is disrupted — by chronic stress, irregular light exposure, late-night eating, or HPA axis dysregulation — evening cortisol remains elevated and melatonin is suppressed.

A 2014 study in Psychoneuroendocrinology found that individuals with higher evening salivary cortisol took significantly longer to fall asleep, had reduced slow-wave sleep, and reported lower subjective sleep quality — even when total sleep duration appeared normal on actigraphy (Vgontzas et al.; PMID: 24434179).

The most rigorously studied adaptogen for cortisol normalization is KSM-66 ashwagandha (Withania somnifera). A double-blind, randomized controlled trial of 64 adults with chronic stress found that 600 mg/day of KSM-66 for 60 days reduced serum cortisol by 27.9% compared to placebo, with corresponding improvements in perceived stress, anxiety, and sleep quality on the Pittsburgh Sleep Quality Index (Chandrasekhar et al., Indian Journal of Psychological Medicine 2012; PMID: 23439798).

A subsequent RCT specifically examining sleep — 150 subjects receiving 300 mg of KSM-66 twice daily for six weeks — found significant improvements in sleep onset latency, total sleep time, and sleep efficiency versus placebo (Langade et al., PLOS ONE 2019; PMID: 31728244).

Rhodiola rosea works synergistically through a different mechanism: rather than lowering cortisol directly, it modulates the stress response by inhibiting cortisol synthesis enzymes under acute stress conditions while supporting serotonin and dopamine balance (Darbinyan et al., Phytomedicine 2000; PMID: 10839209). This makes it particularly useful for people whose sleep disruption is driven by performance anxiety or mental overarousal rather than baseline HPA dysfunction.

If wearable data or lab work shows chronically elevated evening cortisol or a blunted cortisol awakening response, these two adaptogens represent a clinically grounded first line of support — and they pair naturally with understanding how ashwagandha affects cortisol at clinical doses.

---

Magnesium for Sleep: The Deficiency Most People Don't Know They Have

Magnesium is involved in more than 300 enzymatic reactions in the human body, including the synthesis of melatonin and the regulation of GABA receptors — the brain's primary inhibitory neurotransmitter system. When GABA signaling is impaired, the nervous system stays in a state of low-grade excitation that makes sleep onset feel impossible regardless of how tired you are.

The U.S. National Health and Nutrition Examination Survey (NHANES) data consistently shows that approximately 48% of Americans do not meet the Estimated Average Requirement for magnesium from diet alone (Rosanoff et al., Nutrition Reviews 2012; PMID: 22364157). Soil depletion, food processing, alcohol consumption, and chronic stress (which increases urinary magnesium excretion) all drive this gap wider.

A randomized, double-blind, placebo-controlled trial of 46 elderly adults found that 500 mg of magnesium supplementation daily for eight weeks significantly improved subjective sleep quality, sleep efficiency, sleep onset latency, early morning awakening, and insomnia severity index scores compared to placebo (Abbasi et al., Journal of Research in Medical Sciences 2012; PMID: 23853635). Serum melatonin rose, serum cortisol fell, and renin activity increased — all biomarkers of improved sleep physiology.

Form matters enormously here. Magnesium oxide has poor bioavailability (~4%), while magnesium glycinate — magnesium chelated to the amino acid glycine — achieves significantly higher absorption and adds the independent sleep-promoting effect of glycine itself. A study in Sleep and Biological Rhythms found that 3 g of glycine before bedtime reduced fatigue and improved sleep quality in subjects with self-reported unsatisfactory sleep (Bannai et al.; PMID: 22529837).

For a deeper look at dosing and form selection, the optimal magnesium glycinate dosage for sleep guide covers the clinical evidence in full.

---

Vitamin D and Sleep: Why Low Levels Shorten and Fragment Your Rest

Vitamin D receptors are expressed throughout the brain, including in regions that directly govern sleep-wake cycles: the hypothalamus, basal ganglia, and brainstem nuclei responsible for REM regulation. Epidemiological data repeatedly links low 25(OH)D levels to shorter sleep duration, lower sleep efficiency, and higher prevalence of sleep disorders.

A cross-sectional analysis of 3,048 men in the MrOS Sleep Study found that those in the lowest quartile of vitamin D status had significantly shorter sleep duration and higher rates of daytime sleepiness compared to those in the highest quartile (Massa et al., Journal of Clinical Sleep Medicine 2015; PMID: 25979104).

Interventional data is accumulating. A 2017 RCT found that vitamin D3 supplementation (50,000 IU/week for eight weeks in deficient subjects) significantly improved Pittsburgh Sleep Quality Index scores, sleep duration, and reduced daytime sleepiness compared to placebo (Gholami et al., Nutritional Neuroscience 2017; PMID: 28475975).

The relationship between vitamin D and sleep is also mediated through serotonin synthesis — vitamin D activates the gene encoding tryptophan hydroxylase 2, the rate-limiting enzyme for brain serotonin production (Patrick & Ames, FASEB Journal 2015; PMID: 25491371). Since serotonin is the precursor to melatonin, vitamin D deficiency creates a bottleneck in the entire melatonin synthesis pathway.

Vitamin K2 (MK-7) is increasingly recognized as vitamin D's essential cofactor. When vitamin D3 is supplemented in isolation, it increases the demand for K2-dependent proteins (osteocalcin, matrix Gla protein) that require carboxylation. Co-supplementing K2 ensures that calcium mobilized by vitamin D is directed toward bones rather than soft tissues — making the combination both safer and more effective for long-term use. For the full synergy picture, see the vitamin D3 and K2 pairing guide.

Target 25(OH)D levels for sleep optimization appear to be in the 40–60 ng/mL range — a level that approximately 41% of American adults fall below (Forrest & Stuhldreher, Nutrition Research 2011; PMID: 21310306).

---

Sleep Quality Supplements: What the Evidence Supports Beyond the Basics

Once cortisol, magnesium, and vitamin D are addressed, several additional compounds have meaningful clinical evidence for specific aspects of sleep architecture.

L-Theanine

A meta-analysis of nine RCTs found that L-theanine (typically 200–400 mg) significantly improved subjective sleep quality and reduced anxiety — particularly relevant for individuals whose sleep problems are driven by racing thoughts or heightened arousal rather than circadian misalignment (Williams et al., Nutrients 2023; PMID: 36986028). Theanine promotes alpha brain wave activity without causing daytime sedation, making it one of the few sleep aids appropriate for daytime stress management as well.

Omega-3 Fatty Acids (EPA/DHA)

A randomized trial of 362 children found that omega-3 supplementation (600 mg DHA/day) for 16 weeks increased sleep duration by 58 minutes and reduced night waking frequency compared to placebo (Montgomery et al., Journal of Sleep Research 2014; PMID: 24605136). The mechanism likely involves DHA's role in serotonin receptor signaling and its anti-inflammatory effects on the hypothalamus. Adults with low omega-3 index scores show similar patterns of sleep fragmentation. For a deeper look at EPA and DHA ratios, the omega-3 EPA DHA guide explains how to calibrate your dose.

NAC (N-Acetyl Cysteine)

Glutathione depletion — driven by chronic oxidative stress — is increasingly linked to poor sleep quality, particularly in individuals with high alcohol intake, significant exercise loads, or occupational toxin exposure. NAC is the most bioavailable precursor to glutathione. Preclinical data suggests NAC may also modulate glutamate-glutamine cycling in the brain, supporting the shift toward inhibitory (sleep-promoting) neurotransmission (Dean et al., Neuroscience & Biobehavioral Reviews 2011; PMID: 21352845).

Melatonin: Context Matters

Melatonin is not a sedative — it is a circadian signal. It is most effective at low doses (0.5–1 mg) taken 60–90 minutes before the desired sleep time in people with delayed sleep phase or jet lag. It is far less effective as a treatment for sleep maintenance insomnia (waking in the middle of the night), where cortisol dysregulation and magnesium deficiency are more likely the root cause. A Cochrane meta-analysis confirmed melatonin's efficacy for circadian rhythm sleep disorders but found limited evidence for primary insomnia (Herxheimer & Petrie; PMID: 12076414).

---

Lifestyle Architecture: The Non-Negotiable Foundation

No supplement stack fixes sleep that is architecturally broken by behavior. The following evidence-based practices are foundational:

1. Morning light within 30 minutes of waking — outdoor light exposure (>10,000 lux) anchors the cortisol awakening response and advances melatonin onset in the evening (Lewy et al., PNAS 2006; PMID: 16801548).
2. Consistent wake time, seven days a week — sleep restriction therapy evidence shows that a fixed wake time is the single strongest behavioral lever for consolidating sleep (Kyle et al., Sleep Medicine Reviews 2014; PMID: 24680594).
3. Avoid alcohol within 3 hours of bed — alcohol reduces REM sleep in the second half of the night and suppresses growth hormone secretion during early slow-wave sleep (Ebrahim et al., Alcoholism: Clinical and Experimental Research 2013; PMID: 23347102).
4. Keep the bedroom below 67°F (19.4°C) — core body temperature must drop 1–2°F to initiate sleep. Cooler ambient temperatures facilitate this process (Okamoto-Mizuno & Mizuno; PMID: 22738673).
5. Eliminate blue light 90 minutes pre-bed — short-wavelength light suppresses melatonin by up to 85% (Gooley et al., Journal of Clinical Endocrinology & Metabolism 2011; PMID: 21209255).

---

How Ones Addresses This: Building a Personalized Sleep Formula

Sleep disruption is almost never a single-ingredient deficiency — it is a system-level problem that requires a coordinated, data-informed response. This is where Ones' AI-driven approach adds genuine clinical value over off-the-shelf sleep stacks.

When a user uploads blood work (including 25(OH)D, magnesium RBC, cortisol, and inflammatory markers) alongside wearable sleep data (HRV, sleep stages from Oura or WHOOP, resting heart rate trends), the Ones AI identifies which specific drivers are most relevant for that individual.

The resulting formula can include:

• KSM-66 Ashwagandha at 600 mg/day — the exact dose used in the Chandrasekhar 2012 and Langade 2019 RCTs, targeting cortisol normalization and sleep quality improvement.
• Magnesium Glycinate as part of the Ones Magnesium Complex — combining magnesium glycinate with additional magnesium forms to optimize bioavailability and support GABA receptor function without the laxative effect of oxide or citrate at higher doses.
• Vitamin D3 + K2 (MK-7) — dosed based on actual 25(OH)D lab values rather than a one-size-fits-all 1,000 IU standard, paired with K2 to support safe, long-term use.
• Rhodiola Rosea for individuals whose wearable data shows elevated resting heart rate and HRV suppression in the evening — classic signs of unresolved sympathetic nervous system activation.
• Omega-3 EPA/DHA calibrated to omega-3 index results, supporting serotonin signaling, neuroinflammation reduction, and DHA-dependent sleep architecture.

Because Ones formulas are built in 6, 9, or 12-capsule configurations, the sleep-relevant compounds are prioritized within the capsule budget alongside any other health goals — cardiovascular, hormonal, or metabolic — rather than duplicating a generic multivitamin already covering ground that doesn't need covering.

---

Key Takeaways

• Poor sleep is driven by multiple systems simultaneously — cortisol dysregulation, micronutrient deficiencies (especially magnesium and vitamin D), and behavioral patterns all interact and compound each other.
• Evening cortisol elevation is the single most underappreciated sleep disruptor — KSM-66 ashwagandha at 600 mg/day and Rhodiola rosea have the strongest RCT evidence for normalizing it.
• Magnesium glycinate addresses both GABA-mediated sleep onset and melatonin synthesis — and nearly half of Americans are chronically deficient in dietary magnesium.
• Vitamin D below 40 ng/mL shortens sleep duration and fragments architecture — it does so partly by limiting serotonin synthesis, the direct precursor to melatonin.
• Supplement timing and form matter as much as the ingredient itself — magnesium glycinate outperforms oxide, melatonin at 0.5–1 mg is a circadian tool not a sedative, and theanine works best for arousal-type insomnia.
• Ones builds sleep formulas from actual lab and wearable data — targeting the specific deficiencies and hormonal patterns present in that individual rather than defaulting to a generic stack.

Always consult a licensed healthcare provider before beginning a new supplement protocol, particularly if you have a diagnosed sleep disorder, are pregnant, or are taking medications that affect the central nervous system.